Drug Shortage Report for PULMICORT NEBUAMP 0.25 MG/ML
Report ID | 178796 |
Drug Identification Number | 01978918 |
Brand name | PULMICORT NEBUAMP 0.25 MG/ML |
Common or Proper name | budesonide |
Company Name | ASTRAZENECA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | BUDESONIDE |
Strength(s) | 0.25MG |
Dosage form(s) | SUSPENSION |
Route of administration | INHALATION INHALATION |
Packaging size | 20 ampoules |
ATC code | R03BA |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-01-03 |
Actual start date | |
Estimated end date | 2023-01-31 |
Actual end date | 2023-01-03 |
Shortage status | Resolved |
Updated date | 2023-01-04 |
Company comments | Shortage avoided |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-01-04 | French | Compare |
v4 | 2023-01-04 | English | Compare |
v3 | 2023-01-04 | English | Compare |
v2 | 2022-12-16 | French | Compare |
v1 | 2022-12-16 | English | Compare |
Showing 1 to 5 of 5